These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
111 related articles for article (PubMed ID: 2949654)
1. [Electrophysiological research on uterine and ovarian functions in women using intrauterine coils for contraception]. Spektor AM; Blushteĭn LIa; Kozhin AA Akush Ginekol (Mosk); 1986 Nov; (11):50-1. PubMed ID: 2949654 [TBL] [Abstract][Full Text] [Related]
2. Changes of plasminogen activator in human uterine tissue induced by intrauterine contraceptive devices. Shaw ST; Macaulay LK; Sun NC; Tanaka MS; Roche PC Contraception; 1983 Feb; 27(2):131-40. PubMed ID: 6682747 [TBL] [Abstract][Full Text] [Related]
3. Hormonal profile in IUD users. Souka AR; Rahman H; Osman M; Mohei Y; Rizk M Contracept Deliv Syst; 1981 Oct; 2(4):303-10. PubMed ID: 12336991 [TBL] [Abstract][Full Text] [Related]
4. Uterine response to PGE2 with IUDs: a possible mechanism of action and side effect. Toppozada M; Rizk M; Thabet MH; Shaala S Contracept Deliv Syst; 1980 Oct; 1(4):349-63. PubMed ID: 12262137 [TBL] [Abstract][Full Text] [Related]
5. The secretion of human chorionic gonadotropin-like substance in women employing contraceptive measures. Huang SC; Chen HC; Chen RJ; Hsieh CY; Wei PY; Ouyang PC J Clin Endocrinol Metab; 1984 Apr; 58(4):646-53. PubMed ID: 6699130 [TBL] [Abstract][Full Text] [Related]
6. The normal uterus on magnetic resonance imaging and variations associated with the hormonal state. Bartoli JM; Moulin G; Delannoy L; Chagnaud C; Kasbarian M Surg Radiol Anat; 1991; 13(3):213-20. PubMed ID: 1754956 [TBL] [Abstract][Full Text] [Related]
9. Pregnancy-specific beta 1-glycoprotein and chorionic gonadotropin-like immunoreactivity during the latter half of the cycle in women using intrauterine contraception. Seppälä M; Rutanen EM; Jalanko H; Lehtovirta P; Stenman UH; Engvall E J Clin Endocrinol Metab; 1978 Dec; 47(6):1216-9. PubMed ID: 318094 [TBL] [Abstract][Full Text] [Related]
13. Intrauterine devices: an effective alternative to oral hormonal contraception. Prescrire Int; 2009 Jun; 18(101):125-30. PubMed ID: 19637436 [TBL] [Abstract][Full Text] [Related]
14. Do plain plastic and copper bearing intrauterine contraceptive devices have a central mechanism of action? Goldstuck ND Med Hypotheses; 1987 Jun; 23(2):125-30. PubMed ID: 2956487 [TBL] [Abstract][Full Text] [Related]
15. Myometrial activity and the IUCD. II. Propogation waves. Behrman SJ; Archie JT; O'Brien OP Am J Obstet Gynecol; 1969 May; 104(1):123-9. PubMed ID: 5777696 [TBL] [Abstract][Full Text] [Related]
16. [Surgical hysteroscopy in preventing the occurrence of Asherman's syndrome following the removal of intrauterine contraceptive devices]. Davydov SN; Klimenko SA; Orlov VM Akush Ginekol (Mosk); 1988 Aug; (8):70-1. PubMed ID: 3195716 [TBL] [Abstract][Full Text] [Related]
18. [Changes in the levels of precursors of endogenous synthesis of prostaglandins in intrauterine contraception]. Klimets II; Kravchenko EV Akush Ginekol (Mosk); 1989 Oct; (10):63-4. PubMed ID: 2618960 [TBL] [Abstract][Full Text] [Related]
19. Copper IUD emission and its effects on human cervical mucus: spermatozoa interaction. Ros A; Piemonte G; Rugiati S Contracept Deliv Syst; 1980 Apr; 1(2):113-8. PubMed ID: 12336236 [TBL] [Abstract][Full Text] [Related]
20. Serum cortisol level in lactating women using Progestasert system. Askalani H; Badraoui MH; Mahrous T; Osman MI; Bayad MA; Ibrahim II; Abdalla MI Popul Sci; 1981; (2):109-14. PubMed ID: 12339476 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]